Not Available

Award Information
Agency:
Department of Health and Human Services
Amount:
$297,532.00
Program:
SBIR
Contract:
N43CO201000096
Solitcitation Year:
2010
Solicitation Number:
PHS2010-1
Branch:
N/A
Award Year:
2010
Phase:
Phase I
Agency Tracking Number:
N43CO201000096
Solicitation Topic Code:
NCI
Small Business Information
APOLIFE, INC.
100 RIVER PLACE, SUITE 6800, DETROIT, MI, 48207-
Hubzone Owned:
N
Woman Owned:
Y
Socially and Economically Disadvantaged:
N
Duns:
044306905
Principal Investigator
 Nalini Motwani
 (313) 446-2625
 nmotwani@apolife.com
Business Contact
Phone: (313) 446-2625
Email: nmotwani@apolife.com
Research Institution
N/A
Abstract
ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale process for cost effective manufacturing of Campth, anticancer antibody, as a biogeneric antibody candidate. ApoLife has expressed Campath genes in yeast system.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government